TRVI: Trevi Therapeutics, Inc. Company Short-Term Debt
Trevi Therapeutics (TRVI) focuses on developing treatments for chronic cough and pruritus by targeting the CNS to assist patients with incurable pathologies. A stable capital reserve enables the confident advancement of R&D despite stringent regulatory requirements. The metric stands at 0.00. The market valuation trend shown below reflects the impact of Haduvio test results, patent protection, and adherence to spending limits on the share price.
Analytical breakdowns and data insights for company Trevi Corp (TRVI)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity details:
Total Debt to Capital Trevi Therapeutics|TRVI - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Trevi Therapeutics|TRVI - Company Debts|Debts to Book Capitalization Trevi Therapeutics, Inc.|TRVI - Long-Term Debt Volume|Company Current Liabilities Trevi Therapeutics|Quick Liquidity Indicator trevitherapeutics.com
- earnings and valuation multiples indicators:
Fundamental company valuation:Trevi Therapeutics, Inc. (TRVI)
Trevi Therapeutics (TRVI) focuses on high-risk binary research of drugs for the therapy of neurological itch and cough. The dynamics of liabilities maturing within one year reflect current liquidity during the waiting period for FDA verdicts. This metric measures the issuer's ability to service short-term loans without compromising operational activities. By analyzing historical short-term debt data, an investor separates market noise from real financial risks, allowing for a mathematically precise assessment of business resilience.
Competitors of Trevi Therapeutics
BIIB - Company Short-Term Debt|Company Short-Term Loans and Borrowings NBIX (Neurocrine)|Regencell (RGC) - Company Short-Term Debt|Short-Term Debt Axsome Corp (AXSM)|Company Current Liabilities ACAD|XENE (xenon-pharma.com) - Amount of Current Liabilities|Company Short-Term Debt Viking Therapeutics, Inc. (VKTX)|SUPN (Supernus Pharmaceuticals, Inc.) - Company Short-Term Loans and Borrowings|Company Short-Term Debts CPRX (Catalyst Pharmaceuticals Inc)|Denali Corp (DNLI) - Short-Term Debt|HRMY: Company Current Liabilities|BHVN: Company Short-Term Debt|AMLX: Company Short-Term Debts|PRAX - Short-Term Debt Volume|Company Current Liabilities AVXL|CBLL: Company Short-Term Loans and Borrowings|Company Current Liabilities PRTA (Prothena)|Amount of Current Liabilities ALEC|Company Short-Term Debts ANNX (Annexon)|Company Short-Term Loans and Borrowings OMER|Neurogene Corp - Company Short-Term Debts|Short-Term Debt AC Immune Inc|Voyager Therapeutics (VYGR) - Company Short-Term Debt|neumoratx.com - Company Short-Term Loans and Borrowings|SCLX (Scilex) - Company Short-Term Debts|Company Short-Term Debts Tevogen Bio Holdings Inc.|Company Short-Term Debt Alpha Cognition (ACOG)|CGTX: Current Liabilities|Company Short-Term Debts IKT (Inhibikase Therapeutics)|cassavasciences.com (SAVA) - Short-Term Debt|ASRT: Company Current Liabilities|COYA - Company Short-Term Debts|VTGN (vistagen.com) - Company Current Liabilities|OVID: Amount of Current Liabilities|ABOS (Acumen Pharmaceuticals) - Company Short-Term Debts|cervomed.com (CRVO) - Short-Term Debt Volume|Company Short-Term Debts ATHE|Company Current Liabilities clene.com CLNN|Company Short-Term Debt PepGen PEPG|Short-Term Debt Volume jupiterneurosciences.com (JUNS)|RLMD: Company Current Liabilities|annovisbio.com - Amount of Current Liabilities|gracetx.com (GRCE) - Company Short-Term Debt|Firefly Neuroscience, Inc. - Company Short-Term Loans and Borrowings|Company Current Liabilities KLTO|Company Short-Term Debt NRSN|Company Short-Term Debts RVPH|Short-Term Debt Volume metaviatx.com|Company Short-Term Debt NeurAxis NRXS|HSDT: Company Short-Term Indebtedness|Passage Bio Corp - Company Short-Term Debts|Short-Term Debt Neuphoria Therapeutics Inc.|NERV (Minerva Neurosciences) - Company Current Liabilities|athira.com (ATHA) - Company Short-Term Debts|Company Short-Term Debt Addex Therapeutics Ltd|ALZN: Company Short-Term Loans and Borrowings|Company Short-Term Debt Cyclerion Therapeutics (CYCN)|PTIX - Short-Term Debt|Pasithea Therapeutics Corp. - Company Current Liabilities|Amount of Current Liabilities CRGT (Cortigent Inc)|ATXI - Company Short-Term Debt|Company Short-Term Loans and Borrowings BCLI (Brainstorm Cell Therapeutics Inc.)|CARA: Company Short-Term Debts|Short-Term Debt Chromocell (CHRO)|Company Current Liabilities ELYM|Company Short-Term Debt ITCI|Company Short-Term Debts LBPH|Short-Term Debt Volume Marinus Pharmaceuticals Inc|NKGen - Company Current Liabilities|Company Short-Term Loans and Borrowings NRBO|SAGE: Company Current Liabilities|synaptogen.com - Amount of Current Liabilities|TRVN: Company Short-Term Debts|Vigil Neuroscience, Inc. - Company Short-Term Loans and Borrowings|WENA (Anew Medical, Inc.) - Company Short-Term Debts|Short-Term Debt Cerevel Corp CERE